高级检索
史政科, 陈佩佩, 张怡轩, 魏杰, 杜亚楠, 柳晓泉. 上调的miR-452-5p抑制RORα的表达并促进肝癌细胞的增殖和迁移[J]. 中国药科大学学报, 2022, 53(3): 323-332. DOI: 10.11665/j.issn.1000-5048.20220310
引用本文: 史政科, 陈佩佩, 张怡轩, 魏杰, 杜亚楠, 柳晓泉. 上调的miR-452-5p抑制RORα的表达并促进肝癌细胞的增殖和迁移[J]. 中国药科大学学报, 2022, 53(3): 323-332. DOI: 10.11665/j.issn.1000-5048.20220310
SHI Zhengke, CHEN Peipei, ZHANG Yixuan, WEI Jie, DU Yanan, LIU Xiaoquan. Up-regulated miR-452-5p suppressed the expression of RORα and promoted the proliferation and migration of HCC cells[J]. Journal of China Pharmaceutical University, 2022, 53(3): 323-332. DOI: 10.11665/j.issn.1000-5048.20220310
Citation: SHI Zhengke, CHEN Peipei, ZHANG Yixuan, WEI Jie, DU Yanan, LIU Xiaoquan. Up-regulated miR-452-5p suppressed the expression of RORα and promoted the proliferation and migration of HCC cells[J]. Journal of China Pharmaceutical University, 2022, 53(3): 323-332. DOI: 10.11665/j.issn.1000-5048.20220310

上调的miR-452-5p抑制RORα的表达并促进肝癌细胞的增殖和迁移

Up-regulated miR-452-5p suppressed the expression of RORα and promoted the proliferation and migration of HCC cells

  • 摘要: 为了探究肝细胞癌中miR-452-5p对患者预后生存的影响及其对肝癌细胞增殖、迁移的作用。采用肿瘤基因组图谱(TCGA)数据库中肝细胞肝癌数据集对miR-452-5p进行差异表达分析和Kaplan-Meier生存分析。采用TargetscanHuman和miRDB靶基因数据库对miR-452-5p靶基因进行预测;采用基因差异表达分析和加权基因共表达网络分析(WGCNA)的方法对数据集GSE14520进行分析计算。用Lipofectmine-2000将miR-452-5p模拟物、模拟物阴性对照和miR-452-5p抑制剂、抑制剂阴性对照分别转染到Huh7细胞中。分别采用RT-qPCR和Western blot实验,检测4组细胞中RORα在mRNA和蛋白水平上的表达情况。采用CCK-8、Transwell实验,检测4组细胞的增殖活力以及迁移能力。双荧光素酶报告基因实验验证Huh7细胞中miR-452-5p与RORα的调控关系。经TCGA数据分析,miR-452-5p在肝癌组织中高表达且显著影响患者预后总生存期。通过miRNA靶基因预测、基因差异表达分析、WGCNA分析,筛选出关键基因RORα和LAMC1。通过Kaplan-Meier生存分析得知RORα的异常表达显著影响肝癌患者的预后总生存期。肝癌细胞中miR-452-5p的过表达,会降低RORα的mRNA和蛋白表达,同时增强肝癌细胞的增殖能力和迁移能力。双荧光素酶报告基因实验结果证实了miR-452-5p靶向RORα的3′UTR区。在肝细胞癌患者中高表达的miR-452-5p靶向抑制了RORα的表达,促进了肝癌细胞增殖和迁移,进而加剧了肝癌的进展和预后不良。

     

    Abstract: To study the prognosis-related regulation mechanism of miR-452-5p and its influence on the proliferation and migration of hepatocellular carcinoma (HCC) cells, liver hepatocellular carcinoma (LIHC) dataset in The Cancer Genome Atlas (TCGA) was used to validate the differential expression of miR-452-5p and perform the Kaplan-Meier analysis of overall survival (OS).Target genes of miR-452-5p from TargetscanHuman and miRDB databases were predictived; and differentially expressed genes(DEGs) and weighted gene co-expression network analysis (WCGNA) were completed with GSE14520.Lipofectmine-2000 was used to transfect miR-452-5p mimics, mimics negative control, miR-452-5p inhibitor and inhibitor negative control into Huh7 cells,respectively.The mRNA and protein expression level of RORα in 4 groups were determined by RT-qPCR and Western blot.CCK-8 assay and Transwell assay were conducted to testify the capabilities of proliferation and migration.The regulation between miR-452-5p and RORα was confirmed by the dual luciferase reporter assay.After analysis in the TCGA-LIHC dataset, miR-452-5p had higher expression in HCC tissue than that in normal tissue, which was also associated with a shorter OS.RORα and LAMC1 were discriminated by intersecting of DEGs, WGCNA module genes, and predictive target genes.Survival analysis exhibited that dysregulation of RORα was significantly related to the OS.Overexpression of miR-452-5p in HCC cells suppressed the expression of RORα both in mRNA and protein, and also enhanced the viability and migration of HCC cells.The results of the dual luciferase reporter assay showed that miR-452-5p targeted 3′UTR of RORα.Up-regulated miR-452-5p inhibited the expression of RORα, facilitated the proliferation and migration of HCC cells, and promoted the progression and poor prognosis of HCC.

     

/

返回文章
返回